Salwan Al Mutar, Director of Clinical Research at The START Center for Cancer Research, shared Texas Society of Clinical Oncology (TxSCO)’s post on LinkedIn, adding:
“Glad to be invited to discuss with a stellar panel of early clinical trial investigators the current state of clinical trials in TX.
Join our session.
Democratizing Clinical Trials: Bringing Tomorrow’s Oncology Care to Community Clinics on Saturday September 18 at 10:45.
Event info below.”
Quoting TxSCO’s post:
“The speaker line-up for the TxSCO 2026 Annual Conference is here!
September 18-19 at the Gaylord Texan Resort and Convention Center in Grapevine, TX – leaders from across oncology gather to unpack the policy, science, and practice forces reshaping cancer care.
Two keynotes anchor the program:
- Friday: Robert Popovian (Pioneer Institute) on The Policy Landscape Shaping Cancer Drug Pricing and Access
- Saturday: Brian Bourbeau (ASCO) on the 2027 Medicare Proposed Rules and their impact on oncology
From there, the agenda spans policy and legislative updates, clinical trials access, CAR-T, AI in healthcare, pancreatic cancer detection, and more.
Also speaking: Lucas Wong, Lindsay Bealor Greenleaf, Nelda Hunter, Ecaterina (Cathy) Dumbrava, Salwan Al Mutar, Shiraj Sen, Ajit Bisen, Kalyani Narra, Asim Ahmad, Rohan Gupta, Anh Nguyen, Ray Page, Barbara Kenner, Elysa Cortez, Akshat Dayal, Peaches Ulrich, Zachariah Thomas, Mostafa Eysha, Zaid Almubaid, Carole Baas – plus Young Investigator Award winner Emanuele Crupi.
Registration is free – check out the full agenda and reserve your spot.
Other articles about TxSCO on OncoDaily.